Research Article

You have full text access to this OnlineOpen article

Regulation of interleukin-1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts

  1. Salahuddin Ahmed1,*,
  2. Angela Pakozdi1,
  3. Alisa E. Koch2

Article first published online: 25 JUL 2006

DOI: 10.1002/art.22023

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 8, pages 2393–2401, August 2006

Additional Information

How to Cite

Ahmed, S., Pakozdi, A. and Koch, A. E. (2006), Regulation of interleukin-1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatism, 54: 2393–2401. doi: 10.1002/art.22023

Author Information

  1. 1

    University of Michigan Medical School, Ann Arbor

  2. 2

    VA Medical Center and University of Michigan Medical School, Ann Arbor, Michigan

*Department of Internal Medicine/Division of Rheumatology, University of Michigan Medical School, BSRB Room 4388, 109 Zina Pitcher Drive, Ann Arbor, MI 48109-2200

Publication History

  1. Issue published online: 25 JUL 2006
  2. Article first published online: 25 JUL 2006
  3. Manuscript Accepted: 8 MAY 2006
  4. Manuscript Received: 23 DEC 2005

Funded by

  • NIH. Grant Numbers: AI-40987, AR-48267
  • Frederick G. L. Huetwell and William D. Robinson, MD, Professorship in Rheumatology
  • Office of Research and Development, Medical Research Service, Department of Veterans Affairs

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (622K)

REFERENCES

  • 1
    Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis [review]. Nat Rev Immunol 2002; 2: 527–35.
  • 2
    Koch AE. Chemokines and their receptors in rheumatoid arthritis: future targets? [review]. Arthritis Rheum 2005; 52: 710–21.
    Direct Link:
  • 3
    Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction [review]. Clin Immunol 2005; 115: 118–28.
  • 4
    Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, et al. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 2002; 22: 1067–8.
  • 5
    Szekanecz Z, Koch AE. Therapeutic inhibition of leukocyte recruitment in inflammatory diseases [review]. Curr Opin Pharmacol 2004; 4: 423–8.
  • 6
    Unemori EN, Amento EP, Bauer EA, Horuk R. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts: regulation by C-X-C but not C-C cytokines. J Biol Chem 1993; 268: 1338–42.
  • 7
    Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM, et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 2004; 50: 3866–77.
    Direct Link:
  • 8
    Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea. Part I. Review of noncancer health benefits [review]. J Altern Complement Med 2005; 11: 521–8.
  • 9
    Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies [review]. J Nutr 2003; 133: 3275S–84S.
  • 10
    Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 2005; 591: 147–60.
  • 11
    Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 2002; 33: 1097–105.
  • 12
    Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechin-3-gallate inhibits interleukin-1β–induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor κB activation by degradation of the inhibitor of nuclear factor κB. Arthritis Rheum 2002; 46: 2079–86.
    Direct Link:
  • 13
    Singh R, Ahmed S, Malemud CJ, Goldberg VM, Haqqi TM. Epigallocatechin-3-gallate selectively inhibits interleukin-1βinduced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J Orthop Res 2003; 21: 102–9.
    Direct Link:
  • 14
    Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004; 308: 767–73.
  • 15
    Woods JM, Mogollon A, Amin MA, Martinez RJ, Koch AE. The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp Mol Pathol 2003; 74: 282–90.
  • 16
    Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J Biol Chem 2004; 279: 39513–9.
  • 17
    Ahmed S, Wang N, Hafeez BB, Cheruvu VK, Haqqi TM. Punica granatum L. extract inhibits IL-1β–induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-κB in human chondrocytes in vitro. J Nutr 2005; 135: 2096–102.
  • 18
    Jeong JG, Kim JM, Cho H, Hahn W, Yu SS, Kim S. Effects of IL-1β on gene expression in human rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2004; 324: 3–7.
  • 19
    Jackson C, Nguyen M, Arkell J, Sambrook P. Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis—targetting gelatinase A activation [review]. Inflamm Res 2001; 50: 183–6.
  • 20
    Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, et al. Chemokine inhibition—why, when, where, which and how? [review]. Biochem Soc Trans 2004; 32: 366–77.
  • 21
    Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, et al. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 1994; 94: 1012–8.
  • 22
    Taub DD. C-C chemokines: an overview. In: KochAE, StrieterRM, editors. Chemokines in disease. Austin (TX): RG Landes; 1996. p. 27–54.
  • 23
    Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669–71.
  • 24
    Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Haines GK III, et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum 2000; 43: 1266–77.
    Direct Link:
  • 25
    Thornton S, Duwel LE, Boivin GP, Ma Y, Hirsch R. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum 1999; 42: 1109–18.
    Direct Link:
  • 26
    Matsukawa A, Yoshimura T, Fujiwara K, Maeda T, Ohkawara S, Yoshinaga M. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFα, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Lab Invest 1999; 79: 591–600.
  • 27
    Halloran MM, Woods JM, Strieter RM, Szekanecz Z, Volin MV, Hosaka S, et al. The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J Immunol 1999; 162: 7492–500.
  • 28
    Inoue T, Yamashita M, Higaki M. The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1β-stimulated synoviocytes of patients with rheumatoid arthritis. Rheumatol Int 2001; 20: 149–53.
  • 29
    Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005; 315: 1172–80.
  • 30
    Takano K, Nakaima K, Nitta M, Shibata F, Nakagawa H. Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J Agric Food Chem 2004; 52: 4571–6.
  • 31
    Trompezinski S, Denis A, Schmitt D, Viac J. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNFα. Arch Dermatol Res 2003; 295: 112–6.
  • 32
    Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 1997; 57: 117–20.
  • 33
    Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 2005; 52: 1907–19.
    Direct Link:
  • 34
    Guglielmotti A, D'Onofrio E, Coletta I, Aquilini L, Milanese C, Pinza M. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-α production. Inflamm Res 2002; 51: 252–8.
  • 35
    Gong JH, Yan R, Waterfield JD, Clark-Lewis I. Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy. Rheumatology (Oxford) 2004; 43: 39–42.
  • 36
    Youssef S, Maor G, Wildbaum G, Grabie N, Gour-Lavie A, Karin N. C-C chemokine–encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 2000; 106: 361–71.
  • 37
    Walsh DA. Angiogenesis and arthritis [review]. Rheumatology (Oxford) 1999; 38: 103–12.
  • 38
    Murphy G, Crabbe T. Gelatinases A and B. Methods Enzymol 1995; 248: 470–84.
  • 39
    Michaelides MR, Curtin ML. Recent advances in matrix metalloproteinase inhibitors research [review]. Curr Pharm Des 1999; 5: 787–819.
  • 40
    Adcocks C, Collin P, Buttle DJ. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr 2002; 132: 341–6.
  • 41
    Vankemmelbeke MN, Jones GC, Fowles C, Ilic MZ, Handley CJ, Day AJ, et al. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 2003; 270: 2394–403.
    Direct Link:
  • 42
    Close DR. Matrix metalloproteinase inhibitors in rheumatic diseases [review]. Ann Rheum Dis 2001; 60 Suppl 3: iii62–7.
  • 43
    Sridhar SS, Shepherd FA. Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer [review]. Lung Cancer 2003; 42 Suppl 1: S81–91.
  • 44
    Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, et al. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 2003; 31: 88–101.
  • 45
    Ullmann U, Haller J, Decourt JD, Girault J, Spitzer V, Weber P. Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers. Int J Vitam Nutr Res 2004; 74: 269–78.
  • 46
    Levites Y, Amit T, Mandel S, Youdim MB. Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J 2003; 17: 952–4.
  • 47
    Wang SI, Mukhtar H. Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate. Cancer Lett 2002; 182: 43–51.
  • 48
    Lee SJ, Kim DC, Choi BH, Ha H, Kim KT. Regulation of p53 by activated protein kinase C-δ during nitric oxide-induced dopaminergic cell death. J Biol Chem 2006; 281: 2215–24.
  • 49
    Rahman A, Anwar KN, Uddin S, Xu N, Ye RD, Platanias LC, et al. Protein kinase C-δ regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol Cell Biol 2001; 21: 5554–65.
  • 50
    Cummings R, Zhao Y, Jacoby D, Spannhake EW, Ohba M, Garcia JG, et al. Protein kinase Cδ mediates lysophosphatidic acid-induced NF-κB activation and interleukin-8 secretion in human bronchial epithelial cells. J Biol Chem 2004; 279: 41085–94.
View Full Article (HTML) Get PDF (622K)